Silver Book Fact

A statin initiation intervention aimed at Medicare Part D prescription drug plan subscribers with diabetes or coronary artery disease was successful in increasing statin use among this group of members at high risk for cardiovascular events. The estimated coronary event cost avoidance was $12,323 per 220 members who received the intervention.

Stockl K, Tjioe D, Gong S, et al. Effect of an Intervention to Increase Statin Use in Medicare Members Who Qualified for a Medication Therapy Management Program. J Manag Care Pharm. 2008; 14(6): 532-40. https://pubmed.ncbi.nlm.nih.gov/18693777/

Reference

Title
Effect of an Intervention to Increase Statin Use in Medicare Members Who Qualified for a Medication Therapy Management Program
Publication
J Manag Care Pharm
Publication Date
2008
Authors
Stockl K, Tjioe D, Gong S, et al
Volume & Issue
Volume 14, Issue 6
Pages
532-40
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Due to innovation as well as other factors, the death rate in the U.S. from diabetes decreased by 3.9% in 2007 from 2006.  
  • Improvements in key clinical measures over an average of 14.8 months in a community pharmacy health management program called the Diabetes Ten City Challenge, in which 573 patients with diabetes…  
  • Losing about 4 percent of your weight and keeping it off for the rest of your life could reduce your risk for a serious complication from diabetes or from dying…  
  • Treatment of diabetes with medication and other therapy saves $685-$950 in health care costs per patient within 1-2 years.  
  • Economics of DR Treatment
    Laser treatment plus a VEGF inhibitor achieved an incremental cost-effectiveness ratio of $12,410 per quality adjusted life year in patients with DME.